Evidence map›Paper›PMID 35877867›Full record

ArticleMembranes2022

Immobilization of poly(vinyl pyrrolidone) in Polysulfone Membranes by Radically-Initiated Crosslinking Using Potassium Persulfate.

Danae Gonzalez Ortiz, Morgan Nouxet, William Maréchal, Olivier Lorain, André Deratani, Céline Pochat-Bohatier

Abstract read
In one paragraph

Article in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Danae Gonzalez OrtizInstitut Européen des Membranes, IEM UMR 5635, Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Morgan NouxetInstitut Européen des Membranes, IEM UMR 5635, Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
William MaréchalPolymem, 3 Rue de l'Industrie, 31320 Castanet-Tolosan, France.
Olivier LorainPolymem, 3 Rue de l'Industrie, 31320 Castanet-Tolosan, France.
André DerataniInstitut Européen des Membranes, IEM UMR 5635, Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Céline Pochat-BohatierInstitut Européen des Membranes, IEM UMR 5635, Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France.ORCID 0000-0002-9053-2216

Funding

European Regional Development Fund of Region Occitanie AAP Graine 2018 / M2Lab LR0018634
6 · The paper itself

Abstract

Polysulfone (PSU) membranes with poly(vinyl pyrrolidone) (PVP) as a pore-forming and hydrophilic additive were prepared using the non-solvent-induced phase separation (NIPS) technique. PVP immobilization by radical-initiated crosslinking using potassium persulfate (KPS) was studied in view of obtaining membranes with high and long-lasting surface hydrophilicity. A method based on the ATR-FTIR technique was developed to discriminate crosslinked PVP from unreacted PVP in the membrane. The crosslinking progress was investigated as a function of temperature, KPS concentration, and reaction time. The results showed that temperature was the main factor influencing the crosslinking reaction since radical formation is temperature-dependent. Increasing the concentration of KPS and the reaction time led to an increase in the crosslinking rate. The effect of the degree of PVP crosslinking on the structure and properties of the prepared membranes was examined by studying mechanical properties, morphology by SEM, surface hydrophilicity by contact angle measurements, and water permeability.

Indexed as

hydrophilic additivepolymer membranespolysulfonepolyvinylpyrrolidoneradical initiated crosslinking

Identifiers

PMID35877867
PMCPMC9315698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.